TP53 and neoplasm: Bielski et al. [57] sequenced the tumours of 9692 patients with advanced cancers and observed WGD at a prevalence of almost 30%; these WGD+ cancers were associated with increased morbidity and decreased overall survival regardless of age, TP53 mutation, or cancer type.